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Abstract: The Pacific oyster, Crassostrea gigas, is becoming a valuable model for investigating
antiviral defense in the Lophotrochozoa superphylum. In the past five years, improvements
to laboratory-based experimental infection protocols using Ostreid herpesvirus I (OsHV-1) from
naturally infected C. gigas combined with next-generation sequencing techniques has revealed that
oysters have a complex antiviral response involving the activation of all major innate immune
pathways. Experimental evidence indicates C. gigas utilizes an interferon-like response to limit
OsHV-1 replication and spread. Oysters injected with a viral mimic (polyI:C) develop resistance to
OsHV-1. Improved survival following polyI:C injection was found later in life (within-generational
immune priming) and in the next generation (multi-generational immune priming). These studies
indicate that the oyster’s antiviral defense system exhibits a form of innate immune-memory.
An important priority is to identify the molecular mechanisms responsible for this phenomenon. This
knowledge will motivate the development of practical and cost-effective treatments for improving
oyster health in aquaculture.
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1. Introduction
Molluscs are protostomes belonging to the Lophotrochozoa superphylum, the third major bilateral
animal lineage after Deuterostomia and Ecdysozoa [1]. Information has long been scarce on the
antiviral responses of molluscs. The reasons for this poor knowledge are multiple and mostly linked
to the lack of continuous molluscan cell lines for virus propagation and characterisation [2]. Ostreid
herpesvirus 1 (OsHV-1) belongs to the genus Ostreavirus from the family Malacoherpesviridae [3] and
this virus has caused serious economic losses of the Pacific oyster, Crassostrea gigas [4–9]. Thus, OsHV-1
has prompted researchers to study the antiviral defense system of C. gigas. This data provides an
evolutionary link for the development of antiviral defenses between Ecdysozoa and Deuterostomia.
Several literature reviews describing cellular and humoral responses of marine molluscs against
herpesvirus infection have recently been published [10–12], and these will be highlighted where
appropriate. The focus of this review was to ask: how can our current understanding of the antiviral
defenses of C. gigas (i) inform predictions on the evolutionary origins of the antiviral defense systems
of animals, and (ii) reduce the economic impact of viral disease on shellfish aquaculture.
2. Antiviral Defense in the Animal Kingdom
Our understanding of innate antiviral immunity in animals is almost entirely defined by studies
on vertebrates, insects, and nematodes [13–15]. One common theme between these animals is that
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the presence of double-stranded RNA (dsRNA) in virus-infected cells is a key inducer of the innate
antiviral response [15–17]. The innate antiviral defense system of animals has pattern recognition
receptors that sense dsRNA because most viruses, including herpesviruses that have a double-stranded
DNA genome, produce significant amounts of dsRNA during their replication [18]. In general, animals
have the cellular machinery to sense and process virus-derived dsRNA into short interfering RNAs
(viRNAs) by a RNase III endonuclease [19]. When generated, viRNAs are loaded into a multi-subunit
RNA-induced silencing complex (RISC), where they mediate sequence-specific cleavage of the viral
RNA within the cell [19]. Insects and nematodes primarily utilize viRNAs to combat viral infection [20],
whereas vertebrates cells instead use a protein-based defense called the type I interferon (IFN) system
as the major innate antiviral response [15,21]. Viral infection of a vertebrate cell triggers the activation
of a number of pattern recognition receptors (PRRs), with subsequent transcriptional activation of
a family of IFN genes [15]. IFNs are secreted cytokines, released into the extracellular milieu where
they bind specific receptors on the surface of infected and uninfected cells [15]. Receptor engagement
activates signal transduction via the Jak/STAT pathway, leading to the transcription of hundreds of
interferon-stimulated genes (ISGs) that work together to inhibit the cellular processes required by the
virus to replicate and spread [22]. This narrow focus on vertebrates and model invertebrate species
has given the impression that invertebrates use gene silencing by viRNAs to control virus replication,
whereas vertebrates replaced this defense strategy with the IFN system [21,23].
The evolution of antiviral defense strategies in animals cannot be defined so simply. Firstly,
insects also have a protein-based antiviral defense system that permits cell-to-cell communication
of the immune response [24]. Virus-infected insect cells can secrete a peptide, Vago, to activate the
Jak/STAT pathway and limit virus replication in neighbouring cells [25]. Insect cells detect replicating
viruses using Dicer-2, which is central to the RNAi response, to activate Vago via a pathway dependent
on TRAF and Rel2 [26,27]. This data suggests that, although structurally unrelated, Vago may have a
function similar to vertebrate type I IFN cytokines [28]. Secondly, evidence is emerging that mature
mammalian somatic cells can produce highly abundant viRNAs following infection with specific RNA
viruses [29]. Many evolutionary questions arise from these studies on insects and mammals. Did the
IFN and Vago pathways evolve from a common ancestor or arise via convergent evolution? How do
the RNAi and IFN pathways cooperate, complement, or compensate for each other to successfully
control viral infections in animals?
3. Antiviral Defense in the Oyster
Crassostrea gigas and OsHV-1 make an ideal model for studying the antiviral defenses in the
Lophotrochozoa superphylum. Firstly, the genome of C. gigas was sequenced in 2012 [30], providing
an opportunity for the discovery of evolutionarily conserved antiviral immune genes [10]. Secondly,
reproducible laboratory-based experimental infection protocols have been developed using OsHV-1
from naturally infected oysters [31–33]. These tools have revealed C. gigas has a diverse set of antiviral
defense pathways that are equipped with expanded and often novel receptors and adaptors [34,35].
Transcriptome studies reveal an extensive set of C. gigas genes responding to OsHV-1 infection [34–38].
Highly activated genes include key components of the vertebrate type I interferon pathway (Figure 1).
This includes homologs of cytoplasmic virus sensors, such as retinoic acid-inducible gene I (RIG-like
receptors) and toll-like receptors (TLRs) that lack a trans-membrane domain [34]. Homologs of
other interferon-signaling components include interferon-regulatory factors (IRFs), stimulator of
interferon genes (STING), janus kinase (JAK), and signal transducer and activator of transcription
(STAT) [34,37,39]. Several classic interferon stimulate genes (ISGs) are also upregulated in response to
OsHV-1, including double-stranded RNA-specific adenosine deaminase (ADAR) and Viperin [36,37].
It was these data that led researchers to conclude that C. gigas might have an equivalent pathway to
the vertebrate type I IFN pathway [34,37]. However, no obvious homologue of type I IFN cytokine
(or arthropod Vago) has been identified in genomic datasets from C. gigas [10,34].
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Efforts have been made to elucidate the molecular and cellular mechanisms involved in the
oyster’s type I IFN-like pathway, and some recent progress has been made. Poly(I:C) is a synthetic
double-stranded RNA (dsRNA) molecule that has been widely used as a viral mimic in mammalian
and fish models to activate the type I interferon pathway [15,40,41]. Intramuscular injection of
poly(I:C) and other long dsRNA molecules induce an antiviral response in C. gigas that hampers
OsHV-1 replication [42–45]. Oysters have a RIG-1 like receptor (RLR) pathway that senses cytoplasmic
poly(I:C) and transmits signals via mitochondrial antiviral protein (MAVS) to activate NF-κB [46].
C. gigas interferon regulatory factors (IRFs) appear to function downstream of MAVS and were able to
activate the IFN-β and ISG response elements in mammalian cells [46]. Furthermore, the hemolymph
from poly(I:C)-injected C. gigas contains a heat-stable, protease-susceptible factor that induces the
transcription of ISGs in oyster hemocytes, such as Viperin [47]. Viperin is one of the few mammalian
ISGs that have direct antiviral activity against a range of RNA and DNA viruses [48]. C. gigas Viperin
inhibits dengue virus replication when over-expressed in a mammalian cell line [47].
Other antiviral defense pathways must also function in C. gigas, but have received less attention.
Experimental infection of C. gigas with OsHV-1 has shown that surviving oysters can clear OsHV-1
DNA after 24 h post-inoculation [49]. Autophagy is thought to participate in OsHV-1 clearance
and confers a protective role against the virus when induced by carbamazepine or starvation [50].
The OsHV-1 genome encodes many anti-apoptotic proteins that suppress apoptosis in C. gigas
hemocytes and mantle tissue [43,51], despite components of the extrinsic apoptosis pathway being
upregulated in response to OsHV-1 inoculation [34,36]. Other evolutionarily conserved antiviral
pathways are yet to be investigated.
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Figure 1. Conceptual diagram of the interferon-like antiviral response of Crassostrea gigas involving
the TLR/NF-κB, RIG-1/MAVS, and putative cGAS/STING signaling pathways that result in the
transcription of antiviral genes. The oyster genome encodes several novel toll-like receptors (TLRs)
that lack transmembrane domains, implying they have a cytoplasmic function. These novel TLRs
and downstream signaling adaptors are upregulated in response to OsHV-1 inoculation [34,36,52].
The oyster has a functional RIG-1 pathway that senses the presence of cytoplasmic dsRNA (i.e., polyI:C)
and signals via downstream MAVS and TRAF adaptors [46]. The transcription factor IRF appears to
function downstream of oyster MAVS and activates the IFN promoter and IFN stimulated response
elements (ISRE) in mammalian cells [46,53]. Activation of IRF and NF-κB results in their translocation to
the cell nucleus, leading to the transcription of antiviral genes. It is not currently known if oysters have
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a functional cGAS/STING-dependent antiviral response (pathway highlighted with grey arrows) [54].
The oyster genome encodes a STING homologue with three N-terminal transmembrane domains
followed by a STING domain [10]. Oyster STING binds cyclic dinucleotides (CDNs) [55] and interacts
with downstream TBK1 kinase [39]. Functional assays are required to determine if oyster cGAS binds
cytosolic DNA and synthesizes CDNs. Note the unusual protein domains for RIG-like receptors
and STING. Novel RIG-like receptors contain N-terminal death domains and novel STING either
lack transmembrane domains or contain TIR domains [56]. TIR domain-containing proteins such
as TLRs and interleukin-1 receptors are known to play key roles in innate immune signaling [57].
TLR, toll-like receptor; MyD88, myeloid differentiation primary response 88; IRAK, interleukin
receptor-associated kinase; TRAF, TNF-receptor associated factor; IKK, IκB kinase; IκB, Inhibitor of κB;
NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; RIG-1, retinoic acid-inducible
gene-1-like receptor; MAVS, mitochondria antiviral signaling protein; IFN, interferon; IRF, interferon
regulatory factor; cGAS, cyclic GMP-AMP synthase; STING, stimulator of IFN genes; TBK1, tank
binding kinase 1; STAT, signal transducer and activator of transcription; SOCS, suppressor of cytokine
signaling; ISRE, IFN stimulated response element.
4. Evolutionary Origins of Antiviral Defense Systems
Studying the antiviral defenses of oysters has provided important insights into the evolution of
innate immunity. It is currently debated whether vertebrates replaced the antiviral RNAi strategy with
the type I IFN response [21,58]. Explanations for why vertebrates do not utilize RNAi are numerous.
It has been suggested that the strong selective pressure imposed by viruses to inhibit RNAi may
have accelerated the emergence of the vertebrate IFN response [21]. This argument is unlikely given
C. gigas has an antiviral response with striking similarities to the vertebrate IFN response [34,37,42].
Together with genomic data from sponges (phylum: Porifera) [59–61], many key components of the
IFN system appear to have ancient origins. Instead, absence of IFN-related genes in the genomes of
insects (phylum: Arthropoda) and nematodes (phylum: Nematoda) appears to be a result of natural
selection imposed by their viruses.
One of the important questions that remains to be investigated is whether C. gigas utilizes antiviral
RNAi to control viral replication of DNA and RNA viruses. The C. gigas genome encodes the cellular
machinery required for an antiviral RNAi defense system [10,62], but it is not known if this system
is functional. Analysis of bivalve RNA-seq data has revealed numerous RNA and DNA viruses in
C. gigas tissues [63]. Thus, identifying virus-derived siRNAs, by high-throughput sequencing, would
confirm whether C. gigas utilizes this antiviral pathway to control these viruses. This knowledge could
help address the question of why the type I IFN response supplanted siRNA antiviral pathway as the
dominant antiviral innate response in vertebrates [15,23]. In mammalian cells, evidence is mounting
to suggest that the type I IFN and RNAi antiviral systems are incompatible with each other [21].
The type I IFN response shuts down the RNA-induced silencing complex (RISC), and expression of
dicer induces the type I IFN response [64,65]. It is possible that the antiviral RNAi system contributes
little to the oyster’s defense. The oyster genome encodes dicer and ago2, but they are not upregulated
in response to OsHV-1 infection [34].
The innate immune system relies on receptors to detect conserved determinants of microbial
origin [66]. Activation of these receptors initiates signaling cascades that culminate in an effective
immune response. The oyster’s immune system can distinguish between different types of infectious
microorganisms and mount somewhat directed responses [36]. Several antiviral pathways in the
oyster are equipped with expanded and often novel receptors and adaptors [35], which may assist
in tailoring the oyster’s immune response to different types of pathogens. In particular, RIG-like
receptors (RLRs), cyclic GMP-AMP synthase (cGAS), and stimulator of antiviral genes (STING) are all
cytoplasmic viral receptors that belong to multi-gene families that have massively expanded due to
tandem gene duplication and lineage-specific diversification [35,56]. These virus sensors, all known for
their ability to activate the IFN response, often contain novel protein domains that may permit crosstalk
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with other immune pathways [35,56]. Although these virus receptors are classified as cytoplasmic,
the novel domain architecture may enable different virus sensor isoforms to localize in different
cellular compartments—such as endosome, cytosol, or nucleus—and thus provide spatial information
regarding the viral infection [66]. Studies are warranted to determine whether the expansion of virus
receptors assist C. gigas to discriminate different viral pathogens.
It also remains to be determined whether the cGAS-STING pathway exhibits an antiviral function
in oysters, similar to its function in mammalian cells [67]. In mammals, evidence indicates that in
most cell types the cytoplasmic DNA sensor cGAS is essential for induction of type I IFN response
to DNA viruses [54,68]. cGAS binds dsDNA via its zinc ribbon domain and catalyzes the synthesis
of a cyclic dinucleotide (CDN) called cGAMP [69]. cGAMP is a secondary messenger that binds
directly to STING resulting in the conformational reorganization of the C-terminal tail (CTT) domain of
STING that permits recruitment of the downstream TBK1 kinase [69]. TBK1 in turn phosphorylates the
transcription factor IRF3, resulting in IRF3 translocation to the nucleus where it mediates transcription
of IFN and other co-regulated genes [67,70]. The sources of cytoplasmic DNA that induce CDNs
include the genomes of invading pathogens (i.e., intracellular bacteria and DNA viruses) and self-DNA
that has leaked from the nucleus of host cells [67]. Bacteria are also capable of stimulating STING
function by secreting STING activating CDNs (3′,3′ c-di-AMP, cAA) [71]. Phylogenetic analysis of
cGAS and STING gene families showed that their origin could be traced back to the common metazoan
ancestor and these two proteins have co-evolved in unison [55,69]. However, invertebrate cGAS
homologues lack zinc ribbon domains probably required for DNA binding and invertebrate STING
homologues lack the C-terminal tail (CTT) domain that permits recruitment of TBK1 [67,69]. Thus,
it was proposed that invertebrate cGAS-STING pathway cannot sense cytosolic DNA to activate an
antiviral response, but may be evolved in invertebrates as an antibacterial pathway [54,69,72]. Efforts
to elucidate the molecular mechanisms of the oyster’s cGAS-STING pathway have revealed oyster
STING homologs exhibit a robust ability to bind all naturally occurring CDNs, including cGAMP [55].
Furthermore, oyster STING interacts with TBK1 [39], despite lacking a recognizable CTT domain.
Interesting, gene profiling experiments have identified oyster STING and TBK1 are induced by OsHV-1
inoculation and polyI:C stimulation [36,39,73], implying a potential antiviral role. Functional and
biochemical assays are now required to determine whether oyster cGAS homologues sense cytosolic
DNA to synthesize CDNs and if STING/TBK1 can activate oyster IRF resulting in the transcription
of ISGs. It is highly likely that a far more complete understanding of the evolutionary origins of the
cGAS-STING pathway will emerge from further characterization of this oyster pathway in response to
immune stimulatory DNA (ISD) and poly(dA-dT) [74]. This knowledge would help address whether
the cGAS-STING pathway first evolved as an antibacterial or antiviral response.
5. Innate Immune Memory and Antiviral Therapeutic Potential for Shellfish Aquaculture
The shellfish aquaculture industry is desperate to find ways to minimize the economic losses
associated with viral diseases, such as OsHV-1 [75]. So far, oyster farmers have relied on traditional
selective breeding to develop disease-resistant oysters [76] or changing farm husbandry techniques to
reduce mortality by limiting contact time between the oyster and OsHV-1 [77–80]. These approaches
all have inherent problems [81]. Developing disease resistant oysters takes years to achieve and is an
expensive burden for industry [82], whereas changes to farm husbandry has the undesired economic
consequence of reduced growth rates [76,79,80]. Observational experiments investigating the impact of
OsHV-1 on aquaculture production have observed C. gigas that survived a mortality event in the past
appeared to be resistant later in life [83,84]. It also appears this resistance can be passed from generation
to generation. Female C. gigas exposed to non-lethal OsHV-1 infections transmit resistance to their
offspring [85]. The molecular mechanisms that underpin this phenomenon are still to be discovered.
This phenomenon of improved survival upon secondary exposure to OsHV-1 is termed immune
priming to distinguish the innate memory from the mechanistically different adaptive immunity in
vertebrates [86,87]. Several studies have shown immune priming with ribonucleic acids of different
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structures (single or double-stranded) or various lengths (300 bp to 8000 bp) can elicit a protective
antiviral response in C. gigas against subsequent challenge with OsHV-1 [42–45]. This protection is
long-lasting, persisting for at least five months, and the enhanced survival was validated on a shellfish
farm exposed to naturally reoccurring episodes of OsHV-1 [44]. Recent data also suggests that this
protection could be maintained across generations. Offspring (D-veliger oyster larvae) produced from
polyI:C-treated parents had double the chance of surviving exposure to OsHV-1 compared to control
larvae [88]. PolyI:C has no effect on the survival of C. gigas [44,88]. Hence, the enhanced protection
cannot be explained by natural selection.
It is not currently known how the oyster’s immune system is able to store information regarding
previously encountered virus antigens (i.e., dsRNA or polyI:C) to induce resistance upon secondary
exposure to a virus. One intriguing possibility is an epigenetic mechanism, such as DNA methylation
or non-coding RNA that elevates the constitutive gene expression of antiviral effectors [89,90]. This
would allow the oyster’s innate immune system to have plasticity (i.e., memory), as evidenced by
the significant upregulation of oyster ISGs for at least seven days following polyI:C stimulation [91].
Identifying the molecular mechanisms that underpin the oyster’s innate immune memory might
enable a cost-effective therapeutic treatment to mitigate OsHV-1, which would have tremendous
economic benefits for the shellfish aquaculture industry.
6. Conclusions
Research on antiviral defense of the oyster is still in its infancy. In the past five years,
the development of laboratory-based experimental infection protocols combined with next-generation
sequencing has enabled researchers to identify C. gigas has a complex antiviral response [34]. Oysters
have a transcriptional response to viral infection that has striking similarities to the vertebrate type I
IFN response [34,37]. Activating the oysters IFN-like response by injecting C. gigas with polyI:C results
in the upregulation of ISGs that inhibit OsHV-1 replication [42]. As more studies begin to characterize
the antiviral defense responses of the oyster, we see several important questions to be addressed.
These include determining whether the oyster utilizes the siRNA pathway to prevent virus replication
and does the expansion of cytoplasmic and novel virus-recognition receptors enable the oyster to
tailor its antiviral response against specific viruses. The ability of oysters to recognize foreign DNA
(ISD and un-methylated CpG motifs [74]) to induce an antiviral response has yet to be determined.
Purifying and characterizing the cytokine (heat-stable, protease-susceptible factor [47]) that induces
C. gigas ISG expression would also provide valuable new information on the evolutionary origins of
the IFN pathway.
Research into the antiviral defense response of C. gigas is quickly moving from the basic
characterization of evolutionarily conserved antiviral genes to the possibility of using therapeutic
treatments to ‘immunize’ oysters against viral diseases. The concept of innate immune memory in
C. gigas is supported by heterologous immune-priming experiments using polyI:C to elicit long-lasting
protection against OsHV-1 [44]. PolyI:C and its derivatives are non-hazardous synthetic compounds
currently produced as vaccine adjuvants [92]. Thus, multi-generation immune-priming using polyI:C
holds great promise as a cost-effective strategy to breed entire crops of oysters with enhanced protection
against OsHV-1 [88]. The process is safe and would be acceptable to consumers because oysters sold for
human consumption would not have directly been exposed to polyI:C (parents injected with polyI:C).
The credibility of polyI:C as a therapeutic would benefit greatly from description of the molecular
mechanisms underpinning the oyster’s innate immune memory.
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